Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone.

In conclusion, VTE occurred in 5-8% of RRMM patients treated with LD over 2 years, and early-onset VTE was a strong indicator of poor prognosis.
PMID: 30291558 [PubMed - as supplied by publisher]

Source: International Journal of Hematology - October 5, 2018 Category: Hematology Authors: Shin J, Lee JJ, Kim K, Min CK, Lee JO, Suh C, Kim JS, Lee YJ, Yoon SS, Jo JC, Lee HS, Bang SM, Korean Multiple Myeloma 151 Investigators Tags: Int J Hematol Source Type: research